ichorbio

The Bench Brief

Science EN ↓ 2 episoder

Welcome to The Bench Brief, presented by ichorbio. This is the essential channel for life science researchers, PIs, investors, and industry professionals focused on immuno-oncology, antibody development, cell therapy, and drug discovery. The Bench Brief delivers concise, technical presentations directly from leading scientists. We cut the fluff to bring you core data, new applications, and validated protocols. It’s by scientists, for scientists – designed for PhD-level expertise and above. Discover breakthroughs, explore new technologies, and identify potential collaborations or investment opp...

Husk at besøge podcastens hjemmeside og støtte skaberen: ichor.bio

Forfatter

ichorbio

Kategori

Science

Podcastens hjemmeside

ichor.bio

Seneste episode

4. nov. 2025

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Installer gratis Android næsten 10 mio. downloads · 4,7+ i bedømmelse iOS snart

Episoder

Dr. Tommy Gambles: The Future of Multispecific Antibodies just made Bispecifics Obsolete 04.11.2025 15:14

🧬 Advancing a Modular Multispecific Antibody Platform (MATCH) for Hematologic Cancers | Dr. Tommy Gambles, Thera-T Pharmaceutics Dr. Tommy Gambles from Thera-T Pharmaceutics and the University of Utah presents groundbreaking research on the Multi-Antigen T Cell Hybridizers (MATCH) platform. This innovative technology is designed to address the two critical limitations of current T cell therapies:...

Introducing The Bench Brief 04.11.2025 1:24

Welcome to The Bench Brief, presented by ichorbio! This is your essential new resource for deep, technical insights in life sciences, cutting straight to the data that matters. Forget the fluff and marketing speak – we're all about science, by scientists, for scientists. What is The Bench Brief? We bring you concise, 10-15 minute video presentations from leading researchers, principal investigator...